Log In
CQMS
Make a Donation
Log In
Donate
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
      • About Radiation Therapy Quality Assurance
      • QA Policy, Guidelines and Credentialing
      • QA Projects and Collaborations
      • About QA Programs
      • Technical Research Workshop
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Secondary Data Analysis
    • Publications
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2026 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Mission and Values
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
      • About Radiation Therapy Quality Assurance
      • QA Policy, Guidelines and Credentialing
      • QA Projects and Collaborations
      • About QA Programs
      • Technical Research Workshop
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Past Trials
    • Secondary Data Analysis
    • Publications
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2026 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Contact Us
  • Patients and Clinical Trials
    • What is a Clinical Trial?
    • Benefits of participating in a trial
    • Patient Stories
    • Radiation Therapy FAQs
    • Patient Resources
  • Patients and Clinical Trials
    • What is a Clinical Trial?
    • Benefits of participating in a trial
    • Patient Stories
    • Radiation Therapy FAQs
    • Patient Resources
  • Support Us
    • TROG Km’s for Cancer Research Challenge
    • Donate or Fundraise for TROG
    • Ways to Donate
    • TROG Ambassadors
  • Support Us
    • TROG Km’s for Cancer Research Challenge
    • Donate or Fundraise for TROG
    • Ways to Donate
    • TROG Ambassadors
DONATE OR FUNDRAISE
Donate
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
      • About QA Programs
      • About Radiation Therapy Quality Assurance
      • QA Policy, Guidelines and Credentialing
      • QA Projects and Collaborations
      • Technical Research Workshop
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Secondary Data Analysis
    • Publications
  • Benefits of participating in a clinical trial
    • Patient Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
  • Radiation Medicine
  • About Us
    • Our People
      • Our Board
      • Our Staff
    • Corporate Partners
    • Facility Alliance Members
    • President’s Message
    • Strategic Plan 2020-2023
    • Cancer Research Careers
  • Our Research
    • Radiation Therapy Quality Assurance
      • About QA Programs
      • About Radiation Therapy Quality Assurance
      • QA Policy, Guidelines and Credentialing
      • QA Projects and Collaborations
      • Technical Research Workshop
    • All Trials
    • Open Trials – Recruiting
    • Open Trials – In Follow Up
    • Upcoming Trials
    • Past Trials
    • Secondary Data Analysis
    • Publications
  • Benefits of participating in a clinical trial
    • Patient Stories
    • What is a Clinical Trial?
    • Radiation Therapy FAQs
  • Health & Research Professionals
    • Membership
    • New Proposals
    • Events
    • 2025 Annual Scientific Meeting
    • Grants
    • Scientific Committee
  • News & Resources
    • News
    • Glossary
    • Helpful Links
    • Reports
  • Support Us
    • Ways to Donate
    • Donate or fundraise for TROG
    • TROG Ambassadors
  • Contact Us
Read Roland's story about participating in a prostate cancer trial
Catch up with the news from our 2026 Annual Scientific Meeting
Read about TROG's new President-Elect and Board Members
TROG Research Excellence Award winners announced.
First participant recruited for new lung cancer trial
Secondary Data Analysis grant recipient announced

TROG 03.02

    1. Home
    2. Trial
    3. TROG 03.02
  • By w.paterson
  • 14 August, 2021
  • 0 Comments
Completed
Gastrointestinal

A Feasibility Study to Evaluate Adjuvant chemo-radiotherapy for Gastric Cancer

Primary Sponsor

Trans-Tasman Radiation Oncology Group (TROG)

Clinical Trial Registration

Registration Link

Prev Post

TROG 03.06/VCOG PR 01-03 – TOAD

Next Post

CPRR04-EFC4690/TROG 02.02 – HEADSTART

Related Post

14 April, 2026

Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices

LATEST NEWS: 14 April 2026 TROG has made a

9 April, 2026

Vale Professor Jim Denham OAM, TROG founder and world-class researcher

9 April 2026 TROG Cancer Research honours the life

Recent Posts

  • Consumer Engagement Charter cements TROG’s commitment to listen to consumer voices
  • Vale Professor Jim Denham OAM, TROG founder and world-class researcher
  • TROG Secondary Data Analysis Grant awarded to project to better understand prostate cancer therapy outcomes
  • TROG welcomes new Board members and President-Elect
  • TROG’S 38th ASM puts focus on driving innovative trials

Categories

  • Events 19
  • General 22
  • Patient Stories 13
  • Quality Assurance 2
  • Trial publications 9
  • Trials 28
  • TROG Members 16
  • TROG Supporters 6

For over 35 years, Trans Tasman Radiation Oncology Group has been dedicated to improving the way radiation medicine is delivered to cancer patients with ongoing scientific research, clinical trials, and cutting-edge technology.

Facebook-f X-twitter Youtube Instagram Bluesky Streamline Icon: https://streamlinehq.com Bluesky

Quick Links

  • About Us
  • Our Research
  • Patients & Clinical Trials
  • Health & Research Professionals
  • News & Resources
  • Support Us
  • Contact Us

Legalities

  • Privacy Policy
  • Complaints & Feedback
  • Copyright Statement
  • Terms & Conditions
  • Cookie Warning
  • TROG Constitution

Latest News

Keep up to date with TROG news, subscribe to our community newsletter.

Subscribe

ABN:  45 132 672 292

We acknowledge the Traditional Custodians of the lands across Australia and pay respect to Elders past, present and future.

We acknowledge Māori as tangata whenua of Aotearoa New Zealand and as Treaty partners with the Crown as agreed in Te Tiriti o Waitangi.

The content published on this website should not be considered as medical advice and is not intended to replace consultation with an appropriately qualified medical professional.

This website may contain the names and images of people now deceased.

TROG Cancer Research © 2026. All rights reserved

Website developed by the Marketing GP